Functional antagonism between CagA and DLC1 in gastric cancer

被引:2
作者
Hinsenkamp, Isabel [1 ]
Koehler, Jan P. [1 ]
Flaechsenhaar, Christoph [1 ,2 ]
Hitkova, Ivana [1 ]
Meessen, Sabine Eberhart [1 ]
Gaiser, Timo [2 ]
Wieland, Thomas [3 ]
Weiss, Christel [4 ]
Roecken, Christoph [5 ]
Mowat, Michael [6 ]
Quante, Michael [7 ]
Taxauer, Karin [8 ]
Mejias-Luque, Raquel [8 ]
Gerhard, Markus [8 ]
Vogelmann, Roger [1 ]
Meindl-Beinker, Nadja [1 ]
Ebert, Matthias [1 ,9 ,10 ,11 ,12 ]
Burgermeister, Elke [1 ]
机构
[1] Heidelberg Univ, Med Fac Mannheim, Dept Med 2, Mannheim, Germany
[2] Heidelberg Univ, Med Fac Mannheim, Inst Pathol, Mannheim, Germany
[3] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci ECAS, Expt Pharmacol, Mannheim, Germany
[4] Heidelberg Univ, Med Fac Mannheim, Dept Med Stat & Biomath, Mannheim, Germany
[5] Christian Albrechts Univ Kiel, Inst Pathol, Kiel, Germany
[6] Univ Manitoba, CancerCare Manitoba Res Inst, Dept Biochem & Med Genet, Winnipeg, MB, Canada
[7] Univ Med Ctr Freiburg, Fac Med, Dept Med Gastroenterol Hepatol Endocrinol & Infec, Freiburg, Germany
[8] Tech Univ Munich TUM, Sch Med, Inst Med Microbiol Immunol & Hyg, Munich, Germany
[9] Univ Med Ctr, DKFZ Hector Inst, Mannheim, Germany
[10] Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Innate Immunosci MI3, Mannheim, Germany
[11] Heidelberg Univ, Med Fac Mannheim, Ctr Prevent Med & Digital Hlth, Clin Cooperat Unit Hlth Metab, Mannheim, Germany
[12] Heidelberg Univ, Med Fac Mannheim, Mannheim Canc Ctr MCC, Mannheim, Germany
关键词
TUMOR-GROWTH; RHOA; CELL; CHEMOTHERAPY;
D O I
10.1038/s41420-022-01134-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Helicobacter (H.) pylori-induced gastritis is a risk factor for gastric cancer (GC). Deleted-in-liver-cancer-1 (DLC1/ARHGAP7) inhibits RHOA, a downstream mediator of virulence factor cytotoxin-A (CagA) signalling and driver of consensus-molecular-subtype-2 diffuse GC. DLC1 located to enterochromaffin-like and MIST1+ stem/chief cells in the stomach. DLC1+ cells were reduced in H. pylori gastritis and GC, and in mice infected with H. pylori. DLC1 positivity inversely correlated with tumour progression in patients. GC cells retained an N-terminal truncation variant DLC1v4 in contrast to full-length DLC1v1 in non-neoplastic tissues. H. pylori and CagA downregulated DLC1v1/4 promoter activities. DLC1v1/4 inhibited cell migration and counteracted CagA-driven stress phenotypes enforcing focal adhesion. CagA and DLC1 interacted via their N- and C-terminal domains, proposing that DLC1 protects against H. pylori by neutralising CagA. H. pylori-induced DLC1 loss is an early molecular event, which makes it a potential marker or target for subtype-aware cancer prevention or therapy.
引用
收藏
页数:12
相关论文
共 33 条
  • [1] The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity
    Basak, Pratima
    Dillon, Rachelle
    Leslie, Heather
    Raouf, Afshin
    Mowat, Michael R. A.
    [J]. BMC CANCER, 2015, 15
  • [2] Comprehensive molecular characterization of gastric adenocarcinoma
    Bass, Adam J.
    Thorsson, Vesteinn
    Shmulevich, Ilya
    Reynolds, Sheila M.
    Miller, Michael
    Bernard, Brady
    Hinoue, Toshinori
    Laird, Peter W.
    Curtis, Christina
    Shen, Hui
    Weisenberger, Daniel J.
    Schultz, Nikolaus
    Shen, Ronglai
    Weinhold, Nils
    Keiser, David P.
    Bowlby, Reanne
    Sipahimalani, Payal
    Cherniack, Andrew D.
    Getz, Gad
    Liu, Yingchun
    Noble, Michael S.
    Pedamallu, Chandra
    Sougnez, Carrie
    Taylor-Weiner, Amaro
    Akbani, Rehan
    Lee, Ju-Seog
    Liu, Wenbin
    Mills, Gordon B.
    Yang, Da
    Zhang, Wei
    Pantazi, Angeliki
    Parfenov, Michael
    Gulley, Margaret
    Piazuelo, M. Blanca
    Schneider, Barbara G.
    Kim, Jihun
    Boussioutas, Alex
    Sheth, Margi
    Demchok, John A.
    Rabkin, Charles S.
    Willis, Joseph E.
    Ng, Sam
    Garman, Katherine
    Beer, David G.
    Pennathur, Arjun
    Raphael, Benjamin J.
    Wu, Hsin-Ta
    Odze, Robert
    Kim, Hark K.
    Bowen, Jay
    [J]. NATURE, 2014, 513 (7517) : 202 - 209
  • [3] Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations
    Boger, C.
    Kruger, S.
    Behrens, H. M.
    Bock, S.
    Haag, J.
    Kalthoff, H.
    Rocken, C.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (05) : 1005 - 1014
  • [4] TFAP2E-DKK4 and Chemoresistance in Colorectal Cancer
    Ebert, Matthias P. A.
    Taenzer, Marc
    Balluff, Benjamin
    Burgermeister, Elke
    Kretzschmar, Antje Karen
    Hughes, David J.
    Tetzner, Reimo
    Lofton-Day, Catherine
    Rosenberg, Robert
    Reinacher-Schick, Anke C.
    Schulmann, Karsten
    Tannapfel, Andrea
    Hofheinz, Ralf
    Roecken, Christoph
    Keller, Gisela
    Langer, Rupert
    Specht, Katja
    Porschen, Rainer
    Stoehlmacher-Williams, Jan
    Schuster, Tibor
    Stroebel, Philipp
    Schmid, Roland M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01) : 44 - 53
  • [5] CagA-positive Helicobacter pylori strain containing three EPIYA C phosphorylation sites produces increase of G cell and decrease of D cell in experimentally infected gerbils (Meriones unguiculatus)
    Ferreira Junior, Moacir
    Batista, Sergio de Assis
    Barbuto, Rafael Calvao
    Gomes, Adriana Dias
    Magalhaes Queiroz, Dulciene Maria
    Araujo, Ivana Duval
    Caliari, Marcelo Vidigal
    [J]. ADVANCES IN MEDICAL SCIENCES, 2016, 61 (02): : 231 - 236
  • [6] Oncogenic mechanisms of the Helicobacter pylori CagA protein
    Hatakeyama, M
    [J]. NATURE REVIEWS CANCER, 2004, 4 (09) : 688 - 694
  • [7] Inhibition of Rho-Associated Kinase 1/2 Attenuates Tumor Growth in Murine Gastric Cancer
    Hinsenkamp, Isabel
    Schulz, Sandra
    Roscher, Mareike
    Suhr, Anne-Maria
    Meyer, Bjoern
    Munteanu, Bogdan
    Fuchser, Jens
    Schoenberg, Stefan O.
    Ebert, Matthias P. A.
    Waengler, Bjoern
    Hopf, Carsten
    Burgermeister, Elke
    [J]. NEOPLASIA, 2016, 18 (08): : 500 - 511
  • [8] Caveolin-1 Protects B6129 Mice against Helicobacter pylori Gastritis
    Hitkova, Ivana
    Yuan, Gang
    Anderl, Florian
    Gerhard, Markus
    Kirchner, Thomas
    Reu, Simone
    Roecken, Christoph
    Schaefer, Claus
    Schmid, Roland M.
    Vogelmann, Roger
    Ebert, Matthias P. A.
    Burgermeister, Elke
    [J]. PLOS PATHOGENS, 2013, 9 (04)
  • [9] DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA
    Joshi, Rakesh
    Qin, Lyugao
    Cao, Xuan
    Zhong, Shanshan
    Voss, Courtney
    Min, Weiping
    Li, Shawn S. C.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (02) : 645 - 656
  • [10] Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma
    Kakiuchi, Miwako
    Nishizawa, Takashi
    Ueda, Hiroki
    Gotoh, Kengo
    Tanaka, Atsushi
    Hayashi, Akimasa
    Yamamoto, Shogo
    Tatsuno, Kenji
    Katoh, Hiroto
    Watanabe, Yoshiaki
    Ichimura, Takashi
    Ushiku, Tetsuo
    Funahashi, Shinichi
    Tateishi, Keisuke
    Wada, Ikuo
    Shimizu, Nobuyuki
    Nomura, Sachiyo
    Koike, Kazuhiko
    Seto, Yasuyuki
    Fukayama, Masashi
    Aburatani, Hiroyuki
    Ishikawa, Shumpei
    [J]. NATURE GENETICS, 2014, 46 (06) : 583 - 587